「简报」卡耐基梅隆大学表彰 11 名杰出校友；ARPA-H 快速开发新的癌症植入技术

Welcome Back!

以下是本周的校园新闻

CMU

卡耐基梅隆大学表彰 11 名杰出校友

Carnegie Mellon University to Honor 11 Luminary Alumni

10 月 2 日，卡耐基梅隆大学公布了 2023 年校友奖获奖名单。从揭开人类基因组最小组成部分的奥秘，到在最大的屏幕上激励观众，这 11 名校友正在开拓道路，取得个人和职业上的成功，同时回馈了那些追随他们脚步的人。

“对世界产生积极影响的愿望是卡耐基梅隆大学的核心，” Brit McCandless Farmer 说道，他是卡耐基梅隆大学的受托人，兼卡耐基梅隆大学校友会董事会主席，也是 Dietrich 人文与社会科学学院的校友。“今年的校友奖获奖者正是通过他们的专业、职业和为他人服务做到了这一点。这些 Tartans 让我们所有人感到自豪，我很高兴与卡耐基梅隆大学社区分享他们的成就。”

了解更多:

https://www.cmu.edu/engage/about-us/news/alumni/alumniawardshonorees2023.html

Today, Carnegie Mellon University announced the 2023 Alumni Award honorees. From uncovering mysteries within the smallest part of the human genome to delighting audiences on the biggest screens, these 11 alumni are blazing trails and achieving personal and professional successes — all while giving back to those who follow in their footsteps.

“The desire to make a difference and have a positive impact on the world is at the center of the CMU experience,” said Brit McCandless Farmer, CMU trustee, CMU alumni Association Board president and a Dietrich College of Humanities and Social Sciences alumna. “This year’s Alumni Award honorees are doing just that through their professions and vocations and in their service to others. These Tartans make us all proud, and I am thrilled to share their accomplishments with the CMU community.”

Learn More:

https://www.cmu.edu/engage/about-us/news/alumni/alumniawardshonorees2023.html

CMU

ARPA-H 快速开发新的癌症植入技术

ARPA-H Fast Tracks Development of New Cancer Implant Tech

卫生高级研究计划局（ARPA-H）已拨款 4500 万美元用于快速开发感知与响应植入技术，而植入技术将有可能将美国癌症相关的死亡人数减少 50% 以上。

本周宣布，该奖项将颁发给包括卡耐基梅隆大学在内的多机构研究团队，该团队将快速开发和测试一种新的癌症治疗方法，旨在显著改善对于卵巢癌、胰腺癌和其他疑难病症患者的免疫治疗效果。

了解更多:

https://www.cmu.edu/news/stories/archives/2023/september/arpa-h-fast-tracks-development-of-new-cancer-implant-tech

The Advanced Research Projects Agency for Health (ARPA-H) has awarded $45 million to rapidly develop sense-and-respond implant technology that could slash U.S. cancer-related deaths by more than 50%.

Announced this week, the award to a multi-institutional team of researchers, including Carnegie Mellon University, will fast-track development and testing of a new approach to cancer treatment that aims to dramatically improve immunotherapy outcomes for patients with ovarian, pancreatic and other difficult-to-treat cancers.

Learn More:

https://www.cmu.edu/news/stories/archives/2023/september/arpa-h-fast-tracks-development-of-new-cancer-implant-tech